Global and Japan Overactive Bladder (OAB) Therapeutics Market Insights, Forecast to 2027

Global and Japan Overactive Bladder (OAB) Therapeutics Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Overactive Bladder (OAB) Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Overactive Bladder (OAB) Therapeutics Market Size Growth Rate by Type
1.2.2 Anticholinergic Agents
1.2.3 Beta-3 Adrenoreceptor Agonists
1.3 Market by Application
1.3.1 Global Overactive Bladder (OAB) Therapeutics Market Size Growth Rate by Application
1.3.2 Hosptial
1.3.3 Clinci
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Overactive Bladder (OAB) Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Overactive Bladder (OAB) Therapeutics Revenue 2016-2027
2.1.2 Global Overactive Bladder (OAB) Therapeutics Sales 2016-2027
2.2 Global Overactive Bladder (OAB) Therapeutics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Overactive Bladder (OAB) Therapeutics Historical Market Size by Region (2016-2021)
2.3.1 Global Overactive Bladder (OAB) Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Overactive Bladder (OAB) Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Overactive Bladder (OAB) Therapeutics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2022-2027)
2.4.2 Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Region (2022-2027)
3 Global Overactive Bladder (OAB) Therapeutics Competitor Landscape by Players
3.1 Global Top Overactive Bladder (OAB) Therapeutics Manufacturers by Sales
3.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturer (2016-2021)
3.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Overactive Bladder (OAB) Therapeutics Manufacturers by Revenue
3.2.1 Key Overactive Bladder (OAB) Therapeutics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Overactive Bladder (OAB) Therapeutics Revenue by Manufacturers (2016-2021)
3.2.3 Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Overactive Bladder (OAB) Therapeutics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Overactive Bladder (OAB) Therapeutics Revenue in 2020
3.2.6 Global Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Overactive Bladder (OAB) Therapeutics Price by Manufacturers
3.4 Global Overactive Bladder (OAB) Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Overactive Bladder (OAB) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Overactive Bladder (OAB) Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Overactive Bladder (OAB) Therapeutics Market Size by Type (2016-2021)
4.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021)
4.1.2 Global Overactive Bladder (OAB) Therapeutics Revenue by Type (2016-2021)
4.1.3 Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2022-2027)
4.2.1 Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2022-2027)
4.2.2 Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Type (2022-2027)
4.2.3 Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Overactive Bladder (OAB) Therapeutics Market Size by Application (2016-2021)
5.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021)
5.1.2 Global Overactive Bladder (OAB) Therapeutics Revenue by Application (2016-2021)
5.1.3 Overactive Bladder (OAB) Therapeutics Price by Application (2016-2021)
5.2 Overactive Bladder (OAB) Therapeutics Market Size Forecast by Application (2022-2027)
5.2.1 Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2022-2027)
5.2.2 Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Application (2022-2027)
5.2.3 Global Overactive Bladder (OAB) Therapeutics Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
6.1.1 Japan Overactive Bladder (OAB) Therapeutics Sales YoY Growth 2016-2027
6.1.2 Japan Overactive Bladder (OAB) Therapeutics Revenue YoY Growth 2016-2027
6.1.3 Japan Overactive Bladder (OAB) Therapeutics Market Share in Global Market 2016-2027
6.2 Japan Overactive Bladder (OAB) Therapeutics Market Size by Players (International and Local Players)
6.2.1 Japan Top Overactive Bladder (OAB) Therapeutics Players by Sales (2016-2021)
6.2.2 Japan Top Overactive Bladder (OAB) Therapeutics Players by Revenue (2016-2021)
6.3 Japan Overactive Bladder (OAB) Therapeutics Historic Market Review by Type (2016-2021)
6.3.1 Japan Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021)
6.3.2 Japan Overactive Bladder (OAB) Therapeutics Revenue Market Share by Type (2016-2021)
6.3.3 Japan Overactive Bladder (OAB) Therapeutics Price by Type (2016-2021)
6.4 Japan Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2022-2027)
6.4.2 Japan Overactive Bladder (OAB) Therapeutics Revenue Forecast by Type (2022-2027)
6.4.3 Japan Overactive Bladder (OAB) Therapeutics Price Forecast by Type (2022-2027)
6.5 Japan Overactive Bladder (OAB) Therapeutics Historic Market Review by Application (2016-2021)
6.5.1 Japan Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2016-2021)
6.5.2 Japan Overactive Bladder (OAB) Therapeutics Revenue Market Share by Application (2016-2021)
6.5.3 Japan Overactive Bladder (OAB) Therapeutics Price by Application (2016-2021)
6.6 Japan Overactive Bladder (OAB) Therapeutics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2022-2027)
6.6.2 Japan Overactive Bladder (OAB) Therapeutics Revenue Forecast by Application (2022-2027)
6.6.3 Japan Overactive Bladder (OAB) Therapeutics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
7.2 North America Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country
7.2.1 North America Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021)
7.2.2 North America Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Region
8.2.1 Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region (2016-2021)
8.2.2 Asia Pacific Overactive Bladder (OAB) Therapeutics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
9.2 Europe Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country
9.2.1 Europe Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021)
9.2.2 Europe Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
10.2 Latin America Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country
10.2.1 Latin America Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021)
10.2.2 Latin America Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Facts & Figures by Country
11.2.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Overactive Bladder (OAB) Therapeutics Products Offered
12.1.5 Allergan Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Corporation Information
12.2.2 Astellas Pharma Description and Business Overview
12.2.3 Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Astellas Pharma Overactive Bladder (OAB) Therapeutics Products Offered
12.2.5 Astellas Pharma Recent Development
12.3 Hisamitsu Pharmaceutical
12.3.1 Hisamitsu Pharmaceutical Corporation Information
12.3.2 Hisamitsu Pharmaceutical Description and Business Overview
12.3.3 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Products Offered
12.3.5 Hisamitsu Pharmaceutical Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Overactive Bladder (OAB) Therapeutics Products Offered
12.4.5 Pfizer Recent Development
12.5 Ferring
12.5.1 Ferring Corporation Information
12.5.2 Ferring Description and Business Overview
12.5.3 Ferring Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ferring Overactive Bladder (OAB) Therapeutics Products Offered
12.5.5 Ferring Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Description and Business Overview
12.6.3 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Ion Channel Innovations
12.7.1 Ion Channel Innovations Corporation Information
12.7.2 Ion Channel Innovations Description and Business Overview
12.7.3 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Products Offered
12.7.5 Ion Channel Innovations Recent Development
12.8 Kwang Dong Pharmaceutical
12.8.1 Kwang Dong Pharmaceutical Corporation Information
12.8.2 Kwang Dong Pharmaceutical Description and Business Overview
12.8.3 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Products Offered
12.8.5 Kwang Dong Pharmaceutical Recent Development
12.9 Lanzhou Institute of Biological Products
12.9.1 Lanzhou Institute of Biological Products Corporation Information
12.9.2 Lanzhou Institute of Biological Products Description and Business Overview
12.9.3 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Products Offered
12.9.5 Lanzhou Institute of Biological Products Recent Development
12.10 Merck
12.10.1 Merck Corporation Information
12.10.2 Merck Description and Business Overview
12.10.3 Merck Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck Overactive Bladder (OAB) Therapeutics Products Offered
12.10.5 Merck Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Overactive Bladder (OAB) Therapeutics Products Offered
12.11.5 Allergan Recent Development
12.12 Sanofi
12.12.1 Sanofi Corporation Information
12.12.2 Sanofi Description and Business Overview
12.12.3 Sanofi Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sanofi Products Offered
12.12.5 Sanofi Recent Development
12.13 Tengion
12.13.1 Tengion Corporation Information
12.13.2 Tengion Description and Business Overview
12.13.3 Tengion Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Tengion Products Offered
12.13.5 Tengion Recent Development
12.14 Teva Pharmaceutical Industries
12.14.1 Teva Pharmaceutical Industries Corporation Information
12.14.2 Teva Pharmaceutical Industries Description and Business Overview
12.14.3 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Teva Pharmaceutical Industries Products Offered
12.14.5 Teva Pharmaceutical Industries Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Overactive Bladder (OAB) Therapeutics Industry Trends
13.2 Overactive Bladder (OAB) Therapeutics Market Drivers
13.3 Overactive Bladder (OAB) Therapeutics Market Challenges
13.4 Overactive Bladder (OAB) Therapeutics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Overactive Bladder (OAB) Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Overactive Bladder (OAB) Therapeutics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Anticholinergic Agents
Table 3. Major Manufacturers of Beta-3 Adrenoreceptor Agonists
Table 4. Global Overactive Bladder (OAB) Therapeutics Market Size Growth Rate by Application (2021-2027) & (Kg)
Table 5. Global Overactive Bladder (OAB) Therapeutics Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Overactive Bladder (OAB) Therapeutics Sales by Regions (2016-2021) & (Kg)
Table 7. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Regions (2016-2021)
Table 8. Global Overactive Bladder (OAB) Therapeutics Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2022-2027) & (Kg)
Table 10. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturers (2016-2021) (Kg)
Table 14. Global Overactive Bladder (OAB) Therapeutics Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Overactive Bladder (OAB) Therapeutics Manufacturers by Revenue (US$ Million) in 2020
Table 16. Overactive Bladder (OAB) Therapeutics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 18. Global Overactive Bladder (OAB) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Overactive Bladder (OAB) Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder (OAB) Therapeutics as of 2020)
Table 20. Key Manufacturers Overactive Bladder (OAB) Therapeutics Price (2016-2021) (USD/Kg)
Table 21. Overactive Bladder (OAB) Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
Table 23. Date of International Manufacturers Enter into Overactive Bladder (OAB) Therapeutics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Overactive Bladder (OAB) Therapeutics Sales by Type (2016-2021) (Kg)
Table 26. Global Overactive Bladder (OAB) Therapeutics Sales Share by Type (2016-2021)
Table 27. Global Overactive Bladder (OAB) Therapeutics Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Type (2016-2021)
Table 29. Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2022-2027) & (Kg)
Table 31. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2016-2021) (Kg)
Table 36. Global Overactive Bladder (OAB) Therapeutics Sales Share by Application (2016-2021)
Table 37. Global Overactive Bladder (OAB) Therapeutics Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Application (2016-2021)
Table 39. Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2022-2027) & (Kg)
Table 41. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Overactive Bladder (OAB) Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Overactive Bladder (OAB) Therapeutics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. Japan Overactive Bladder (OAB) Therapeutics Sales (Kg) of Key Companies (2016-2021)
Table 46. Japan Overactive Bladder (OAB) Therapeutics Sales Share by Company (2016-2021)
Table 47. Japan Overactive Bladder (OAB) Therapeutics Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Overactive Bladder (OAB) Therapeutics Revenue Share by Company (2016-2021)
Table 49. Japan Overactive Bladder (OAB) Therapeutics Sales (Kg) by Type (2016-2021)
Table 50. Japan Overactive Bladder (OAB) Therapeutics Sales Share by Type (2016-2021)
Table 51. Japan Overactive Bladder (OAB) Therapeutics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Overactive Bladder (OAB) Therapeutics Price (USD/Kg) by Type (2016-2021)
Table 53. Japan Overactive Bladder (OAB) Therapeutics Sales (Kg) by Type (2022-2027)
Table 54. Japan Overactive Bladder (OAB) Therapeutics Sales Share by Type (2022-2027)
Table 55. Japan Overactive Bladder (OAB) Therapeutics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Overactive Bladder (OAB) Therapeutics Revenue Share by Type (2022-2027)
Table 57. Japan Overactive Bladder (OAB) Therapeutics Price (USD/Kg) by Type (2022-2027)
Table 58. Japan Overactive Bladder (OAB) Therapeutics Sales (Kg) by Application (2016-2021)
Table 59. Japan Overactive Bladder (OAB) Therapeutics Sales Share by Application (2016-2021)
Table 60. Japan Overactive Bladder (OAB) Therapeutics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Overactive Bladder (OAB) Therapeutics Price (USD/Kg) by Application (2016-2021)
Table 62. Japan Overactive Bladder (OAB) Therapeutics Sales (Kg) by Application (2022-2027)
Table 63. Japan Overactive Bladder (OAB) Therapeutics Sales Share by Application (2022-2027)
Table 64. Japan Overactive Bladder (OAB) Therapeutics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Overactive Bladder (OAB) Therapeutics Revenue Share by Application (2022-2027)
Table 66. Japan Overactive Bladder (OAB) Therapeutics Price (USD/Kg) by Application (2022-2027)
Table 67. North America Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg)
Table 68. North America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021)
Table 69. North America Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region (2016-2021) & (Kg)
Table 72. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Overactive Bladder (OAB) Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region (2016-2021)
Table 75. Europe Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg)
Table 76. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021)
Table 77. Europe Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021)
Table 79. Latin America Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg)
Table 80. Latin America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Country (2016-2021) & (Kg)
Table 84. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Overactive Bladder (OAB) Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Overactive Bladder (OAB) Therapeutics Revenue Market Share by Country (2016-2021)
Table 87. Allergan Corporation Information
Table 88. Allergan Description and Business Overview
Table 89. Allergan Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. Allergan Overactive Bladder (OAB) Therapeutics Product
Table 91. Allergan Recent Development
Table 92. Astellas Pharma Corporation Information
Table 93. Astellas Pharma Description and Business Overview
Table 94. Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Astellas Pharma Product
Table 96. Astellas Pharma Recent Development
Table 97. Hisamitsu Pharmaceutical Corporation Information
Table 98. Hisamitsu Pharmaceutical Description and Business Overview
Table 99. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Hisamitsu Pharmaceutical Product
Table 101. Hisamitsu Pharmaceutical Recent Development
Table 102. Pfizer Corporation Information
Table 103. Pfizer Description and Business Overview
Table 104. Pfizer Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Pfizer Product
Table 106. Pfizer Recent Development
Table 107. Ferring Corporation Information
Table 108. Ferring Description and Business Overview
Table 109. Ferring Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. Ferring Product
Table 111. Ferring Recent Development
Table 112. GlaxoSmithKline Corporation Information
Table 113. GlaxoSmithKline Description and Business Overview
Table 114. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. GlaxoSmithKline Product
Table 116. GlaxoSmithKline Recent Development
Table 117. Ion Channel Innovations Corporation Information
Table 118. Ion Channel Innovations Description and Business Overview
Table 119. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Ion Channel Innovations Product
Table 121. Ion Channel Innovations Recent Development
Table 122. Kwang Dong Pharmaceutical Corporation Information
Table 123. Kwang Dong Pharmaceutical Description and Business Overview
Table 124. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Kwang Dong Pharmaceutical Product
Table 126. Kwang Dong Pharmaceutical Recent Development
Table 127. Lanzhou Institute of Biological Products Corporation Information
Table 128. Lanzhou Institute of Biological Products Description and Business Overview
Table 129. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Lanzhou Institute of Biological Products Product
Table 131. Lanzhou Institute of Biological Products Recent Development
Table 132. Merck Corporation Information
Table 133. Merck Description and Business Overview
Table 134. Merck Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. Merck Product
Table 136. Merck Recent Development
Table 137. ONO Pharmaceutical Corporation Information
Table 138. ONO Pharmaceutical Description and Business Overview
Table 139. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. ONO Pharmaceutical Product
Table 141. ONO Pharmaceutical Recent Development
Table 142. Sanofi Corporation Information
Table 143. Sanofi Description and Business Overview
Table 144. Sanofi Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 145. Sanofi Product
Table 146. Sanofi Recent Development
Table 147. Tengion Corporation Information
Table 148. Tengion Description and Business Overview
Table 149. Tengion Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 150. Tengion Product
Table 151. Tengion Recent Development
Table 152. Teva Pharmaceutical Industries Corporation Information
Table 153. Teva Pharmaceutical Industries Description and Business Overview
Table 154. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 155. Teva Pharmaceutical Industries Product
Table 156. Teva Pharmaceutical Industries Recent Development
Table 157. Overactive Bladder (OAB) Therapeutics Market Trends
Table 158. Overactive Bladder (OAB) Therapeutics Market Drivers
Table 159. Overactive Bladder (OAB) Therapeutics Market Challenges
Table 160. Overactive Bladder (OAB) Therapeutics Market Restraints
Table 161. Overactive Bladder (OAB) Therapeutics Customers List
Table 162. Overactive Bladder (OAB) Therapeutics Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Overactive Bladder (OAB) Therapeutics Product Picture
Figure 2. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type in 2020 & 2027
Figure 3. Anticholinergic Agents Product Picture
Figure 4. Beta-3 Adrenoreceptor Agonists Product Picture
Figure 5. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2020 & 2027
Figure 6. Hosptial
Figure 7. Clinci
Figure 8. Other
Figure 9. Overactive Bladder (OAB) Therapeutics Report Years Considered
Figure 10. Global Overactive Bladder (OAB) Therapeutics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Overactive Bladder (OAB) Therapeutics Market Size 2016-2027 (US$ Million)
Figure 12. Global Overactive Bladder (OAB) Therapeutics Sales 2016-2027 (Kg)
Figure 13. Global Overactive Bladder (OAB) Therapeutics Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2016-2021)
Figure 15. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2020
Figure 16. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region (2016-2021)
Figure 17. Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Region in 2020
Figure 18. Global Overactive Bladder (OAB) Therapeutics Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Overactive Bladder (OAB) Therapeutics Revenue in 2020
Figure 20. Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2016-2021)
Figure 22. Global Overactive Bladder (OAB) Therapeutics Sales Mark

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs